The global superdisintegrants market size is expected to reach USD 829.54 million by 2032, according to a new study by Polaris Market Research. The report "Superdisintegrants Market Share, Size, Trends, Industry Analysis Report, By Product (Modified Starch, Modified Cellulose, Crospovidone, Ion Exchange Resin); By Formulation; By Therapeutic Area; By Region; Segment Forecast, 2023-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The rising prevalence of chronic diseases such as cardiovascular diseases, diabetes, and cancer has increased the demand for drugs. Superdisintegrants play a vital role in formulating these drugs, making them essential components in the pharmaceutical industry. The most non-communicable disease deaths (NCD), 17.9 million per year, are caused by cardiovascular diseases, followed by cancer (9.3 million), chronic respiratory conditions (4.1 million), and diabetes (1.2 million) (2.0 million, including fatalities from renal disease brought on by diabetes)). This will drive the growth of the market in the upcoming years.
Advancements in technology have led to the development of new and more efficient super disintegrants. For instance, recent studies have investigated using banana powder as a super disintegrant in various pharmaceutical formulations, including tablets and capsules. This has led to increased use of these excipients in formulating multiple drugs. The demand for generic drugs is rising due to their affordability and accessibility.
The increasing use of super disintegrants in the pharmaceutical industry, coupled with the growing number of patents being filed for new and innovative solutions, is driving the growth of the super disintegrants market. According to the combination of data from the National Institute of Standards & Technology (NIST) and the United Nations Patent and Trademark Office (USPTO), N-Vinyl pyrrolidone+sodium starch glycolate has 15 patents, followed by Amylose with 14 patents. This trend is expected to continue in the coming years as drug manufacturers seek to develop more efficient and effective drug delivery systems.
Superdisintegrants Market Report Highlights
Crospovidone segment is anticipated to grow due to increasing demand for fast dissolving dosage forms.
Tablets segment is registered the highest growth rate owing to the as tablets are the most used dosage form in the pharmaceutical industry and superdisintegrants are critical ingredients in tablet formulations.
Gastrointestinal diseases are projected to experience significant growth rate due to the growing incidence of GI disorders and increased focus on patient-centric drug delivery.
North America is expected to have the largest revenue share owing to the strong increasing incidence of chronic diseases and technological advancements.
APAC is projected to witness significant growth rate in the coming years due to the growing pharmaceutical industry in developing countries like China and India.
The global players include: BASF, Ashland Global, Dow DuPont, Roquette Freres, DFE Pharma, JRS PHARMA, Asahi Kasei, Merck, Corel Pharma & Avantor Performance.
Polaris Market Research has segmented the superdisintegrants market report based on product, formulation, therapeutic area, and region:
Superdisintegrants, Product Outlook (Revenue - USD Million, 2019 - 2032)
- Modified Starch
- Modified Cellulose
- Crospovidone
- Ion Exchange Resin
Superdisintegrants, Formulation Outlook (Revenue - USD Million, 2019 - 2032)
Superdisintegrants, Therapeutic area Outlook (Revenue - USD Million, 2019 - 2032)
- Gastrointestinal Diseases
- Neurological Diseases
- Oncology
- Infectious Diseases
- Cardiovascular Diseases
- Hematological Diseases
- Inflammatory Diseases
Superdisintegrants, Regional Outlook (Revenue - USD Million, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
3. Research Methodology
- 3.1. Overview
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Superdisintegrants Market Insights
- 4.1. Superdisintegrants Market - Therapeutic Area Snapshot
- 4.2. Superdisintegrants Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Growing Adoption of Orally Disintegrating Tablets
- 4.2.1.2. Growing Generics Market
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Safety and Quality Concerns
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Superdisintegrants Market Therapeutic Area Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Superdisintegrants Market, by Product
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Superdisintegrants Market, by Product, 2019-2032 (USD Million)
- 5.3. Modified Starch
- 5.3.1. Global Superdisintegrants Market, by Modified Starch, by Region, 2019-2032 (USD Million)
- 5.4. Modified Cellulose
- 5.4.1. Global Superdisintegrants Market, by Modified Cellulose, by Region, 2019-2032 (USD Million)
- 5.5. Crospovidone
- 5.5.1. Global Superdisintegrants Market, by Crospovidone, by Region, 2019-2032 (USD Million)
- 5.6. Ion Exchange Resin
- 5.6.1. Global Superdisintegrants Market, by Ion Exchange Resin, by Region, 2019-2032 (USD Million)
6. Global Superdisintegrants Market, by Formulation
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
- 6.3. Tablets
- 6.3.1. Global Superdisintegrants Market, by Tablets by Region, 2019-2032 (USD Million)
- 6.4. Capsules
- 6.4.1. Global Superdisintegrants Market, by Capsules, by Region, 2019-2032 (USD Million)
7. Global Superdisintegrants Market, by Therapeutic Area
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
- 7.3. Gastrointestinal Diseases
- 7.3.1. Global Superdisintegrants Market, by Gastrointestinal Diseases, By Region, 2019-2032 (USD Million)
- 7.4. Neurological Diseases
- 7.4.1. Global Superdisintegrants Market, by Neurological Diseases, By Region, 2019-2032 (USD Million)
- 7.5. Oncology
- 7.5.1. Global Superdisintegrants Market, by Oncology, By Region, 2019-2032 (USD Million)
- 7.6. Infectious Diseases
- 7.6.1. Global Superdisintegrants Market, by Infectious Diseases, By Region, 2019-2032 (USD Million)
- 7.7. Cardiovascular Diseases
- 7.7.1. Global Superdisintegrants Market, by Cardiovascular Diseases, By Region, 2019-2032 (USD Million)
- 7.8. Hematological Diseases
- 7.8.1. Global Superdisintegrants Market, by Hematological Diseases, By Region, 2019-2032 (USD Million)
- 7.9. Inflammatory Diseases
- 7.9.1. Global Superdisintegrants Market, by Inflammatory Diseases, By Region, 2019-2032 (USD Million)
8. Global Superdisintegrants Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Superdisintegrants Market Assessment, By Geography, 2019-2032 (USD Million)
- 8.3. Superdisintegrants Market - North America
- 8.3.1. North America: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
- 8.3.2. North America: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
- 8.3.3. North America: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
- 8.3.4. Superdisintegrants Market - U.S.
- 8.3.4.1. U.S.: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
- 8.3.4.2. U.S.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
- 8.3.4.3. U.S.: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
- 8.3.5. Superdisintegrants Market - Canada
- 8.3.5.1. Canada: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
- 8.3.5.2. Canada.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
- 8.3.5.3. Canada: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
- 8.4. Superdisintegrants Market - Europe
- 8.4.1. Europe: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
- 8.4.2. Europe.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
- 8.4.3. Europe: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
- 8.4.4. Superdisintegrants Market - UK
- 8.4.4.1. UK: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
- 8.4.4.2. UK.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
- 8.4.4.3. UK: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
- 8.4.5. Superdisintegrants Market - France
- 8.4.5.1. France: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
- 8.4.5.2. France.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
- 8.4.5.3. France: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
- 8.4.6. Superdisintegrants Market - Germany
- 8.4.6.1. Germany: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
- 8.4.6.2. Germany.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
- 8.4.6.3. Germany: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
- 8.4.7. Superdisintegrants Market - Italy
- 8.4.7.1. Italy: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
- 8.4.7.2. Italy.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
- 8.4.7.3. Italy: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
- 8.4.8. Superdisintegrants Market - Spain
- 8.4.8.1. Spain: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
- 8.4.8.2. Spain.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
- 8.4.8.3. Spain: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
- 8.4.9. Superdisintegrants Market - Netherlands
- 8.4.9.1. Netherlands: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
- 8.4.9.2. Netherlands.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
- 8.4.9.3. Netherlands: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
- 8.4.10. Superdisintegrants Market - Russia
- 8.4.10.1. Russia: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
- 8.4.10.2. Russia.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
- 8.4.10.3. Russia: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
- 8.5. Superdisintegrants Market - Asia Pacific
- 8.5.1. Asia Pacific: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
- 8.5.2. Asia Pacific.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
- 8.5.3. Asia Pacific: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
- 8.5.4. Superdisintegrants Market - China
- 8.5.4.1. China: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
- 8.5.4.2. China.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
- 8.5.4.3. China: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
- 8.5.5. Superdisintegrants Market - India
- 8.5.5.1. India: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
- 8.5.5.2. India.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
- 8.5.5.3. India: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
- 8.5.6. Superdisintegrants Market - Malaysia
- 8.5.6.1. Malaysia: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
- 8.5.6.2. Malaysia.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
- 8.5.6.3. Malaysia: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
- 8.5.7. Superdisintegrants Market - Japan
- 8.5.7.1. Japan: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
- 8.5.7.2. Japan.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
- 8.5.7.3. Japan: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
- 8.5.8. Superdisintegrants Market - Indonesia
- 8.5.8.1. Indonesia: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
- 8.5.8.2. Indonesia.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
- 8.5.8.3. Indonesia: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
- 8.5.9. Superdisintegrants Market - South Korea
- 8.5.9.1. South Korea: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
- 8.5.9.2. South Korea.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
- 8.5.9.3. South Korea: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
- 8.6. Superdisintegrants Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
- 8.6.2. Middle East & Africa.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
- 8.6.3. Middle East & Africa: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
- 8.6.4. Superdisintegrants Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
- 8.6.4.2. Saudi Arabia.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
- 8.6.4.3. Saudi Arabia: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
- 8.6.5. Superdisintegrants Market - UAE
- 8.6.5.1. UAE: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
- 8.6.5.2. UAE.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
- 8.6.5.3. UAE: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
- 8.6.6. Superdisintegrants Market - Israel
- 8.6.6.1. Israel: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
- 8.6.6.2. Israel.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
- 8.6.6.3. Israel: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
- 8.6.7. Superdisintegrants Market - South Africa
- 8.6.7.1. South Africa: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
- 8.6.7.2. South Africa.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
- 8.6.7.3. South Africa: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
- 8.7. Superdisintegrants Market - Latin America
- 8.7.1. Latin America: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
- 8.7.2. Latin America.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
- 8.7.3. Latin America: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
- 8.7.4. Superdisintegrants Market - Mexico
- 8.7.4.1. Mexico: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
- 8.7.4.2. Mexico.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
- 8.7.4.3. Mexico: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
- 8.7.5. Superdisintegrants Market - Brazil
- 8.7.5.1. Brazil: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
- 8.7.5.2. Brazil.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
- 8.7.5.3. Brazil: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
- 8.7.6. Superdisintegrants Market - Argentina
- 8.7.6.1. Argentina: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
- 8.7.6.2. Argentina.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
- 8.7.6.3. Argentina: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. BASF
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Roquette Freres
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Ashland Global
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Dow DuPont
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. DFE Pharma
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Asahi Kasei
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Merck
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Corel Pharma & Avantor Performance.
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development